ARID1A and cholangiocarcinoma: There were 9 of 13 tumors (69%) with loss of ARID1A expression and 25 of 41 tumors (61%) with low ARID1A expression exhibited distant metastasis (p = 0.028, adjusted p-value = 0.168), suggesting that ARID1A may play a role in CCA progression.